Search Results

There are 9777 results for: content related to: Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer

  1. You have free access to this content
    Management of advanced hepatocellular carcinoma in the era of targeted therapy

    Liver International

    Volume 29, Issue 1, January 2009, Pages: 10–17, Thomas Yau, Pierre Chan, Richard Epstein and Ronnie Tung Ping Poon

    Version of Record online : 12 DEC 2008, DOI: 10.1111/j.1478-3231.2008.01916.x

  2. Bevacizumab (Avastin)

    Handbook of Therapeutic Antibodies

    Eduardo Díaz-Rubio, Edith A. Perez, Guiseppe Giaccone, Pages: 779–812, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch29

  3. You have free access to this content
    Targeted therapy: An evolving world of lung cancer

    Respirology

    Volume 16, Issue 1, January 2011, Pages: 13–21, Kwok-Chi LAM and Tony S. MOK

    Version of Record online : 16 AUG 2010, DOI: 10.1111/j.1440-1843.2010.01821.x

  4. You have free access to this content
    Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma

    Cancer

    Volume 113, Issue 4, 15 August 2008, Pages: 808–814, David M. Jackman, Hedy L. Kindler, Beow Y. Yeap, Panos Fidias, Ravi Salgia, Joan Lucca, Linda K. Morse, Patricia A. Ostler, Bruce E. Johnson and Pasi A. Jänne

    Version of Record online : 9 JUN 2008, DOI: 10.1002/cncr.23617

  5. You have free access to this content
    RESEARCH POSTER ABSTRACTS

    Value in Health

    Volume 13, Issue 7, November 2010, Pages: A250–A480,

    Version of Record online : 11 OCT 2010, DOI: 10.1111/j.1524-4733.2010.00791_2.x

  6. Anti-Angiogenic Agents in Metastatic NSCLC

    Lung Cancer, Fourth Edition

    Millie Das, Heather Wakelee, Pages: 527–540, 2014

    Published Online : 4 APR 2014, DOI: 10.1002/9781118468791.ch34

  7. You have free access to this content
    RESEARCH PODIUM ABSTRACTS

    Value in Health

    Volume 13, Issue 7, November 2010, Pages: A239–A250,

    Version of Record online : 11 OCT 2010, DOI: 10.1111/j.1524-4733.2010.00791_1.x

  8. You have free access to this content
    Maintenance therapy in nonsmall-cell lung cancer

    Cancer

    Volume 115, Issue 22, 15 November 2009, Pages: 5143–5154, Tony S. K. Mok and Suresh S. Ramalingam

    Version of Record online : 5 AUG 2009, DOI: 10.1002/cncr.24563

  9. Advanced or Metastatic Pancreatic Cancer: Molecular Targeted Therapies

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 6, November/December 2010, Pages: 606–619, Soley Bayraktar and Caio M. Rocha-Lima

    Version of Record online : 23 NOV 2010, DOI: 10.1002/msj.20217

  10. You have free access to this content
    Targeted therapy of hepatocellular carcinoma: Present and future

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 5, May 2012, Pages: 862–872, Stephen L Chan and Winnie Yeo

    Version of Record online : 20 APR 2012, DOI: 10.1111/j.1440-1746.2012.07096.x

  11. You have free access to this content
    Molecular targeted therapies in hepatocellular carcinoma

    Hepatology

    Volume 48, Issue 4, October 2008, Pages: 1312–1327, Josep M. Llovet and Jordi Bruix

    Version of Record online : 8 JUL 2008, DOI: 10.1002/hep.22506

  12. Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck

    Head & Neck

    Volume 37, Issue 11, November 2015, Pages: 1665–1671, Min Yao, Nicholas Galanopoulos, Pierre Lavertu, Pingfu Fu, Michael Gibson, Athanassios Argiris, Rod Rezaee, Chad Zender, Jay Wasman, Mitchell Machtay and Panos Savvides

    Version of Record online : 29 OCT 2014, DOI: 10.1002/hed.23813

  13. You have free access to this content
    Safety profile of combined therapy inhibiting EFGR and VEGF pathways in patients with advanced non-small-cell lung cancer: A meta-analysis of 15 phase II/III randomized trials

    International Journal of Cancer

    Volume 137, Issue 2, 15 July 2015, Pages: 409–419, Wang Ma, Mingxin Xu, Yiqian Liu, Hao Liu, Jiale Huang, Yanjie Zhu, Li-juan Ji and Xiaolong Qi

    Version of Record online : 12 DEC 2014, DOI: 10.1002/ijc.29377

  14. You have free access to this content
    RESEARCH PODIUM ABSTRACTS

    Value in Health

    Volume 12, Issue 7, October 2009, Pages: A221–A237,

    Version of Record online : 15 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00592_1.x

    Corrected by:

    Erratum

    Vol. 13, Issue 2, 335, Version of Record online: 17 DEC 2009

  15. You have free access to this content
    Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies

    Cancer

    Volume 121, Issue 7, April 1, 2015, Pages: 997–1007, Kathryn M. Field, Justin T. Jordan, Patrick Y. Wen, Mark A. Rosenthal and David A. Reardon

    Version of Record online : 26 SEP 2014, DOI: 10.1002/cncr.28935

  16. Tumor Microenvironment, Angiogenesis Biology, and Targeted Therapy

    Lung Cancer, Fourth Edition

    John V. Heymach, Tina Cascone, Pages: 505–526, 2014

    Published Online : 4 APR 2014, DOI: 10.1002/9781118468791.ch33

  17. EGFR Tyrosine Kinase Inhibitors and Monoclonal Antibodies: Clinical Trial Review

    Lung Cancer, Fourth Edition

    Kathryn F. Mileham, Edward S. Kim, William N. William, Pages: 406–420, 2014

    Published Online : 4 APR 2014, DOI: 10.1002/9781118468791.ch26

  18. You have free access to this content
    RESEARCH POSTER ABSTRACTS

    Value in Health

    Volume 12, Issue 7, October 2009, Pages: A237–A460,

    Version of Record online : 15 SEP 2009, DOI: 10.1111/j.1524-4733.2009.00592_2.x

    Corrected by:

    Erratum

    Vol. 13, Issue 1, 158, Version of Record online: 17 DEC 2009

  19. You have free access to this content
    Anti-angiogenesis drugs in lung cancer

    Respirology

    Volume 15, Issue 3, April 2010, Pages: 387–392, Siow Ming LEE, Paul BAAS and Heather WAKELEE

    Version of Record online : 19 MAR 2010, DOI: 10.1111/j.1440-1843.2010.01715.x

  20. A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 18, Issue 3, May/June 2008, Pages: 400–406, J.D. WRIGHT, A.A. SECORD, T.M. NUMNUM, R.P. ROCCONI, M.A. POWELL, A. BERCHUCK, R.D. ALVAREZ, R.K. GIBB, K. TRINKAUS, J.S. RADER and D.G. MUTCH

    Version of Record online : 21 JUL 2007, DOI: 10.1111/j.1525-1438.2007.01027.x